Adrenomed’s goal is to fill the gap in patient treatment further downstream of inflammation with Adrecizumab, the first sepsis therapy candidate to target an important causal pathophysiology of ...
Despite similar clinical presentations, the molecular and cellular processes that elicit the sepsis response differ depending on whether the organism is gram-negative, gram-positive, fungal ...
The Harvard Pilgrim Health Care Institute is proud to announce the launch of the Center for Sepsis Epidemiology and ...
Sepsis is an underestimated killer. Nearly a quarter of patients treated for sepsis in hospital will die, but because so many ...
It's a copycat killer—often mimicking less severe conditions and delaying much-needed, timely treatments. But sepsis—an ...
Like a poison pen, dying cells prick their neighbors with a lethal message. This may worsen sepsis, Vijay Rathinam and colleagues in the UConn School of Medicine report in the Jan. 23 issue of Cell.
One night he was looking after a baby boy who had sepsis, which is where the immune ... It feels like we're discovering ...
It's a copycat killer - often mimicking less severe conditions and delaying much-needed, timely treatments. But sepsis - an infection that can lead to ...
The American College of Chest Physicians and the Society of Critical Care Medicine (ACCP/SCCM) developed consensus definitions for sepsis in 1992. [6] There has been much discussion about the ...